95 related articles for article (PubMed ID: 21778905)
21. [A case of mixed connective tissue disease with lupus-like manifestations of the central nervous system, successfully treated with cyclophosphamide combined with prednisolone].
Kuroki M; Okayama A; Kuwata G; Okamoto M; Tanaka G; Iga M; Kai Y; Matsuyama M; Murai K; Tsubouchi H
Ryumachi; 2000 Jun; 40(3):627-32. PubMed ID: 10920688
[TBL] [Abstract][Full Text] [Related]
22. Association of chronic interstitial cystitis, protein-losing enteropathy and paralytic ileus with seronegative systemic lupus erythematosus: case report and review of the literature.
Meulders Q; Michel C; Marteau P; Grange JD; Mougenot B; Ronco P; Mignon F
Clin Nephrol; 1992 May; 37(5):239-44. PubMed ID: 1606774
[TBL] [Abstract][Full Text] [Related]
23. Pulse cyclophosphamide treatment for severe refractory cutaneous lupus erythematosus.
Raptopoulou A; Linardakis C; Sidiropoulos P; Kritikos HD; Boumpas DT
Lupus; 2010 May; 19(6):744-7. PubMed ID: 20179172
[TBL] [Abstract][Full Text] [Related]
24. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.
Yee CS; Gordon C; Dostal C; Petera P; Dadoniene J; Griffiths B; Rozman B; Isenberg DA; Sturfelt G; Nived O; Turney JH; Venalis A; Adu D; Smolen JS; Emery P
Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482
[TBL] [Abstract][Full Text] [Related]
25. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
Jais X; Launay D; Yaici A; Le Pavec J; Tchérakian C; Sitbon O; Simonneau G; Humbert M
Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
[TBL] [Abstract][Full Text] [Related]
26. [Clinical and immunological study of a case of mixed connective tissue disease (MCTD) with onset in childhood].
Cottafava F; Bertolotto M; Brida di Priò S; Moni L; Grossi-Bianchi ML
Minerva Pediatr; 1978 Dec; 30(24):1927-32. PubMed ID: 753959
[No Abstract] [Full Text] [Related]
27. Transverse myelitis in mixed connective tissue disease.
Pedersen C; Bonen H; Boesen F
Clin Rheumatol; 1987 Jun; 6(2):290-2. PubMed ID: 3621848
[TBL] [Abstract][Full Text] [Related]
28. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation.
Thacker D; Patel A; Dodds K; Goldberg DJ; Semeao E; Rychik J
Ann Thorac Surg; 2010 Mar; 89(3):837-42. PubMed ID: 20172140
[TBL] [Abstract][Full Text] [Related]
29. Combination of immunoadsorption and CD20 antibody therapy in a patient with mixed connective tissue disease.
Rech J; Kallert S; Hueber AJ; Requadt C; Kalden JR; Schulze-Koops H
Rheumatology (Oxford); 2006 Apr; 45(4):490-1. PubMed ID: 16461439
[No Abstract] [Full Text] [Related]
30. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
[TBL] [Abstract][Full Text] [Related]
31. [Mixed connective tissue disease: progress in diagnosis and treatment. II. Physiopathology and diagnosis. 5. Mixed connective tissue disease with its onset in childhood--results of a nationwide survey].
Yokota S; Imagawa T; Mori M; Mitsuda T; Aihara Y
Nihon Naika Gakkai Zasshi; 1996 Aug; 85(8):1217-22. PubMed ID: 8965017
[No Abstract] [Full Text] [Related]
32. Ten year survival of a patient with advanced pulmonary hypertension and mixed connective tissue disease treated with immunosuppressive therapy.
Dahl M; Chalmers A; Wade J; Calverley D; Munt B
J Rheumatol; 1992 Nov; 19(11):1807-9. PubMed ID: 1491407
[TBL] [Abstract][Full Text] [Related]
33. Pediatric Mixed Connective Tissue Disease.
Berard RA; Laxer RM
Curr Rheumatol Rep; 2016 May; 18(5):28. PubMed ID: 27032791
[TBL] [Abstract][Full Text] [Related]
34. [Interstitial pneumonia associated with mixed connective tissue disease--marked improvement with azathioprine].
Suzuki M; Shimizu K; Sakamoto K; Iwase A; Aoki S; Matsuoka R; Nagayama T; Kitamura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jan; 34(1):101-5. PubMed ID: 8717301
[TBL] [Abstract][Full Text] [Related]
35. Protein-losing enteropathy: integrating a new disease paradigm into recommendations for prevention and treatment.
Meadows J; Jenkins K
Cardiol Young; 2011 Aug; 21(4):363-77. PubMed ID: 21349233
[TBL] [Abstract][Full Text] [Related]
36. The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation.
John AS; Driscoll DJ; Warnes CA; Phillips SD; Cetta F
Ann Thorac Surg; 2011 Oct; 92(4):1451-6. PubMed ID: 21784410
[TBL] [Abstract][Full Text] [Related]
37. Transverse myelitis in primary Sjögren's syndrome: usefulness of low-dose oral cyclophosphamide rather than pulse therapy.
Quartuccio L; Ferraccioli GF; De Vita S
Scand J Rheumatol; 2006; 35(5):409-10. PubMed ID: 17062445
[No Abstract] [Full Text] [Related]
38. Recurrent bilateral optic neuropathy in mixed connective tissue disease.
Gressel MG; Tomsak RL
J Clin Neuroophthalmol; 1983 Jun; 3(2):101-4. PubMed ID: 6224807
[TBL] [Abstract][Full Text] [Related]
39. [Mixed connective tissue disease].
Prøven A
Tidsskr Nor Laegeforen; 1992 Feb; 112(4):479-82. PubMed ID: 1553696
[TBL] [Abstract][Full Text] [Related]
40. Lupus-associated protein-losing enteropathy.
Perednia DA; Curosh NA
Arch Intern Med; 1990 Sep; 150(9):1806-10. PubMed ID: 2203319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
